Skip to main content

Find Clinical Trials

Home
Conditions
Vomiting

Clinical trial condition

Vomiting

Explore clinical trials studying Vomiting. Study availability and eligibility vary by location and protocol.

542 public trials 47 recruiting studies

Refine in advanced search Browse all conditions

Vomiting trial results

Completed

Aprepitant and Fosaprepitant Time-on-Target PET (Positron Emission Tomography) Study (0869-183)

NCT01111851

Conditions: Chemotherapy-Induced Nausea and Vomiting (CINV), Pathological Conditions, Signs and Symptoms, Signs and Symptoms, +2 more
Locations: Not specified

View Trial Details

Completed

Prospective Controlled Trial On Clear Feeds Versus Low Residue Diet After Surgery In Elective Colorectal Surgery Patients

NCT01890499

Conditions: Nausea, Nausea/Vomiting, Pathological Conditions, Signs and Symptoms, +3 more
Locations: Cedars Sinai Medical Center Los Angeles, California, United States

View Trial Details

Completed

A Study to Assess the Bioequivalence of Aprepitant and Fosaprepitant and the Effect of Food on Aprepitant Bioavailability (0869-165)

NCT00945321

Conditions: Chemotherapy-induced Nausea and Vomiting, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, +2 more
Locations: Not specified

View Trial Details

Completed

Randomized Crossover Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Granisetron in Cancer Patients

NCT00450853

Conditions: Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, +1 more
Locations: Clinica Universitaria de Navarra Pamplona, Navarre, Spain

View Trial Details

Completed

Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Palonosetron in Cancer Treated With Chemotherapy

NCT01046240

Conditions: Emesis, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, +2 more
Locations: Clinica Universidad de Navarra Pamplona, Navarre, Spain

View Trial Details

Completed

Study to Evaluate Anti-emetic Effect of Aprepitant Versus Placebo in Children and Adolescent Receiving Chemotherapy

NCT01402024

Conditions: Chemotherapy Induced Nausea and Vomiting, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, +2 more
Locations: Dr. BRA IRCH, AIIMS New Delhi, National Capital Territory of Delhi, India

View Trial Details

Completed

Comparison of the Effects of Neostigmine With Sugammadex on Postoperative Nausea and Vomiting.

NCT02286752

Conditions: Incidence of Postoperative Nausea and Vomiting, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, +2 more
Locations: Anesthesiology and Reanimation Dept. Ordu University Training and Research Hospital Altinordu, Ordu, Turkey (Türkiye)

View Trial Details

Completed

Epidemiological EMESIS-Registry

NCT00911222

Conditions: Antiemetic Therapy, Nausea, Pathological Conditions, Signs and Symptoms, +3 more
Locations: iOMEDICO AG Freiburg im Breisgau, Baden-Wurttemberg, Germany

View Trial Details

Completed

Prophylactic Subhypnotic Propofol for Nausea and Vomiting During for Cesarean Section Under Subarachnoid Anesthesia.

NCT01781377

Conditions: Nausea, Pathological Conditions, Signs and Symptoms, Pregnancy, +3 more
Locations: A.O. SS.ma Annunziata Chieti, Italy

View Trial Details

Completed

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

NCT01339260

Conditions: Chemotherapy-induced Nausea and Vomiting, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, +2 more
Locations: Anniston Oncology/Regional Medical Center Anniston, Alabama, United States

Northwest Alabama Cancer Center Muscle Shoals, Alabama, United States

Genesis Cancer Centre Hot Springs, Arkansas, United States

Compassionate Cancer Care Medical Group Inc Corona, California, United States

View all 172 locations

View Trial Details